HBV Citations List: September 2022

Literature Citations

1. Selected Ginsenosides Interfere Efficiently with Hepatitis B Virus mRNA Expression Levels and Suppress Viral Surface Antigen Secretion. Duraisamy, G.S., E. Jo, I. Huvarová, K.P. Park, Z. Heger, V. Adam, D. Růžek, M.P. Windisch, and A.D. Miller. Heliyon, 2022. 8(9): e10465. PMID[36110238]. PMCID[PMC9468399].
[PubMed]. HBV_09_2022.

2. Discovery and Preclinical Evaluations of GST-HG131, a Novel HBV Antigen Inhibitor for the Treatment of Chronic Hepatitis B Infection. Hu, Y., F. Sun, Q. Yuan, J. Du, L. Hu, Z. Gu, Q. Zhou, X. Du, S. He, Y. Sun, Q. Wang, L. Fan, L. Wang, S. Qin, S. Chen, J. Li, W. Wu, J. Mao, Y. Zhou, Q. Zhou, G. Zhang, and C.Z. Ding. Bioorganic & Medicinal Chemistry Letters, 2022. 75: 128977. PMID[36089112].
[PubMed]. HBV_09_2022.

3. Design, Synthesis, and Evaluation of a Set of Carboxylic acid and Phosphate Prodrugs Derived from HBV Capsid Protein Allosteric Modulator NVR 3-778. Ji, X., X. Jiang, C. Kobayashi, Y. Ren, L. Hu, Z. Gao, D. Kang, R. Jia, X. Zhang, S. Zhao, K. Watashi, X. Liu, and P. Zhan. Molecules, 2022. 27(18): 5987. PMID[36144715]. PMCID[PMC9505734].
[PubMed]. HBV_09_2022.

4. The anti‑Hepatitis B Virus Activity of Sea Buckthorn Is Attributed to Quercetin, Kaempferol and Isorhamnetin. Parvez, M.K., M.S. Al-Dosari, O.A. Basudan, and R.N. Herqash. Biomedical Reports, 2022. 17(5): 89. PMID[36185785]. PMCID[PMC9500493].
[PubMed]. HBV_09_2022.

Patent Citations

This month, no relevant HBV patents were identified.